{"disease":{"id":"norovirus","name":"norovirus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06592794","title":"A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":37864,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT05916326","title":"Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":8000,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT06524947","title":"Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6600,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT04941261","title":"Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":1716,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT05992935","title":"Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1407,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT02153112","title":"Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":840,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03039790","title":"Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":528,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04188691","title":"A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":510,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT02142504","title":"Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02038907","title":"Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":420,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02661490","title":"Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT05212168","title":"Norovirus Challenge Study","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Vaxart","has_results":true},{"nct_id":"NCT05626803","title":"A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Vaxart","has_results":true},{"nct_id":"NCT01609257","title":"Norovirus Bivalent-Vaccine Efficacy Study","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03897309","title":"Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Vaxart","has_results":false},{"nct_id":"NCT07254728","title":"A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Vaxart","has_results":true},{"nct_id":"NCT04854746","title":"Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Vaxart","has_results":false},{"nct_id":"NCT02868073","title":"Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Vaxart","has_results":false},{"nct_id":"NCT03125473","title":"Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Vaxart","has_results":false},{"nct_id":"NCT06944717","title":"A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Vaxart","has_results":false},{"nct_id":"NCT05508178","title":"Recombinant, Bivalent, Norovirus Vaccine Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Icon Genetics GmbH","has_results":false},{"nct_id":"NCT02475278","title":"Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04174560","title":"Phase I Norovirus Challenge Model","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02473224","title":"Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07198139","title":"A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Cocrystal Pharma, Inc.","has_results":false},{"nct_id":"NCT03395405","title":"NNITS-Nitazoxanide for Norovirus in Transplant Patients Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04875676","title":"Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Vaxart","has_results":true},{"nct_id":"NCT03721549","title":"Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"WCCT Global","has_results":true},{"nct_id":"NCT05213728","title":"A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Vaxart","has_results":false}],"total":30},"guidelines":[],"source":"Drug Landscape verified database"}